ORIENTBIO Inc. (002630) — Cash Flow-to-Debt Ratio
ORIENTBIO Inc. (002630) has a Cash Flow-to-Debt Ratio of 0.14x as of December 2025, meaning its operating cash flow of ₩1.77 Billion could theoretically repay 0% of its total liabilities (₩12.64 Billion) in one year. See ORIENTBIO Inc. (002630) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
ORIENTBIO Inc. Cash Flow-to-Debt Ratio (2007–2025)
Historical debt coverage capacity for ORIENTBIO Inc. across 16 annual periods. Also explore ORIENTBIO Inc. equity growth rate to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for ORIENTBIO Inc. (2007–2025)
Year-by-year debt coverage analysis for ORIENTBIO Inc.. For market capitalisation and broader financial context, see how much is ORIENTBIO Inc. worth.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.06x | ₩752.29 Million | ₩12.94 Billion | ▼ -81.6% |
| 2024 | 0.32x | ₩3.76 Billion | ₩11.89 Billion | ▲ +163.0% |
| 2023 | 0.12x | ₩1.16 Billion | ₩9.66 Billion | ▲ +11.2% |
| 2022 | 0.11x | ₩2.35 Billion | ₩21.76 Billion | ▼ -71.6% |
| 2021 | 0.38x | ₩8.74 Billion | ₩22.97 Billion | ▲ +296.3% |
| 2020 | -0.19x | ₩-3.90 Billion | ₩20.14 Billion | ▲ +64.0% |
| 2019 | -0.54x | ₩-11.54 Billion | ₩21.44 Billion | ▼ -2913.4% |
| 2018 | -0.02x | ₩-1.97 Billion | ₩110.11 Billion | ▲ +73.9% |
| 2017 | -0.07x | ₩-5.11 Billion | ₩74.68 Billion | ▼ -732.3% |
| 2016 | 0.01x | ₩912.43 Million | ₩84.35 Billion | ▼ -45.1% |
| 2015 | 0.02x | ₩1.60 Billion | ₩81.42 Billion | ▼ -29.4% |
| 2014 | 0.03x | ₩2.17 Billion | ₩77.78 Billion | ▼ -59.5% |
| 2013 | 0.07x | ₩5.09 Billion | ₩73.95 Billion | ▼ -57.2% |
| 2011 | 0.16x | ₩3.11 Billion | ₩19.38 Billion | ▼ -26.9% |
| 2010 | 0.22x | ₩9.35 Billion | ₩42.55 Billion | ▲ +305.7% |
| 2007 | 0.05x | ₩1.52 Billion | ₩28.02 Billion | — |